InvestorsHub Logo
Followers 87
Posts 32823
Boards Moderated 1
Alias Born 12/19/2004

Re: None

Thursday, 02/18/2021 8:50:30 AM

Thursday, February 18, 2021 8:50:30 AM

Post# of 30351
Seelos Therapeutics Announces Amendment of SLS-002 Agreement to Repurchase a Significant Portion of Royalties for SLS-002 (Intranasal Racemic Ketamine Program)

https://www.chartmill.com/news/SEEL/prnews-2021-2-18-seelos-therapeutics-announces-amendment-of-sls-002-agreement-to-repurchase-a-significant-portion-of-royalties-for-sls-002-intranasal-racemic-ketamine-program
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News